Clinical trial
Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic…
NCT00472953 · Novo Nordisk A/S, Industry · Terminated
Key facts
| NCT number | NCT00472953 |
|---|---|
| Title | Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD) |
| Official title | Inhaled Pre-prandial Human Insulin Versus Subcutaneous Injected Insulin Aspart in Subjects With Diabetes and Chronic Obstructive Pulmonary Disease: A 52-week Open Label, Multicentre, Randomized, Parallel Trial to Investigate Long-term Safety |
| Acronym | iINHALE 8 |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1, Type 2, Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | inhaled human insulin, insulin aspart |
| Enrollment | 38 |
| Start date | May 15, 2007 |
| Primary completion | Mar 5, 2008 |
| Completion | Mar 5, 2008 |
| First posted | May 14, 2007 |
| Last update posted | Mar 1, 2017 |
| Countries | Argentina, India, Romania, Slovakia, Taiwan, Thailand, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: